Simultaneous detection and subtyping of H274Y-positive influenza a (H1N1) using pyrosequencing

Journal of Infection in Developing Countries

Volumn 5, Issue 5, 2011, Pages 348-352

  Chantratita, Wasun ^a   Sukasem, Chonlaphat ^a   Sirinavin, Sayomporn ^a   Sankuntaw, Nipaporn ^a   Srichantaratsamee, Chutatip ^a   Pasomsub, Ekawat ^a   Malathum, Kumthorn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

H274y; Influenza a (h1n1); Oseltamivir; Pyrosequencing

Indexed keywords

ANTIPYRETIC AGENT; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CASE REPORT; COUGHING; DISEASE DURATION; FEVER; GENOTYPE; HUMAN; HUMAN TISSUE; INFLUENZA VIRUS A H1N1; MALAISE; MALE; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PALLIATIVE THERAPY; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SORE THROAT; THAILAND; VIRUS DETECTION; VIRUS MUTATION;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 79958103399     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1197     Document Type: Article

References (11)

1. Moscona A (2005) Oseltamivir resistance--disabling our influenza defenses. N Engl J Med 353: 2633-2636.
2. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83: 90-93.
3. Deyde VM, Nguyen T, Bright RA, Balish A, Shu B, Lindstrom S, Klimov AI, Gubareva LV (2009) Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrob Agents Chemother 53: 1039-1047.
4. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52: 3284-3292.
5. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15: 552-560.
6. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
7. Cheng PK, To AP, Leung TW, Leung PC, Lee CW, Lim WW (2010) Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerg Infect Dis 16: 155-156.
8. Dharan NJ, Patton M, Siston AM, Morita J, Ramirez E, Wallis TR, Deyde V, Gubareva LV, Klimov AI, Bresee JS, Fry AM (2009) Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008. Emerg Infect Dis 15: 1973-1976.
9. Fourment M, Mardy S, Channa M, Buchy P (2010) Evidence for persistence of and antiviral resistance and reassortment events in seasonal influenza virus strains circulating in Cambodia. J Clin Microbiol 48: 295-297.
10. Bai GR, Chittaganpitch M, Kanai Y, Li YG, Auwanit W, Ikuta K, Sawanpanyalert P (2009) Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand. Biochem Biophys Res Commun 390: 897-901.
11. Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney J, Manamela JM, Blumberg L, Schoub BD (2008) Widespreadoseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 14: 1809-1810.